This information is specific to Ireland and is not intended to replace the advice of a healthcare professional. Please consult your healthcare professional for further advice and information on your condition and medication.
Aciclovir 200mg/5mg Oral Suspension is indicated for the treatment of herpes simple virus infections of the skin and the mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and sever HSV infections in immunocompromised children)
Aciclovir Suspension is indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immunocompetent patients.
Aciclovir Suspension is indicated for the prophylaxis of herpes simplex infections in immunocompromised patients.
Aciclovir Suspension is indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections. Studies have shown that early treatment of shingles with Aciclovir Suspension has a beneficial effect on pain and can reduce the incidence of post-herpetic neuralgia (zoster-associated pain).
Presentation: Oral Suspension
Ire: PA22697/001/001
Authorised Distributor:
Kora Corporation Limited t/a Kora Healthcare
20 Harcourt Street
Dublin
D02 H364
Ireland
Marketing Authorisation Holder:
Syri Pharma Limited t/a Thame Laboratories
Floor 0, 1 WML
1 Windmill Lane,
Dublin 2, Ireland
Date of Preparation January 2025
508-01